Chinese vape makers use nicotine analogs to bypass US regulations

Chinese vape manufacturers are selling products containing chemicals known as nicotine analogs, which may be more potent than nicotine itself, according to a recent investigation. These substances, such as 6-methyl-nicotine, are being used to circumvent U.S. regulations that restrict nicotine levels in vaping liquids. The practice affects American consumers, particularly youth, who may be exposed to unregulated and potentially stronger addictive compounds. This matters because nicotine analogs have not been approved by the U.S. Food and Drug Administration (FDA) for use in vaping products, raising concerns about their safety and addictiveness. The investigation found that at least 20 different Chinese companies are marketing these products online, with some offering 6-methyl-nicotine at concentrations up to 5%—similar to the nicotine levels found in many e-cigarettes. Big Tobacco companies had studied nicotine analogs for decades but never brought them to market due to safety and regulatory hurdles. The FDA has not yet taken action against these products, but experts warn that they could pose a significant public health risk, especially as they may appeal to young people. The next steps could involve increased scrutiny from U.S. regulators and potential enforcement actions to prevent the sale of these unapproved substances.